Peptides Related to the Carboxyl Terminus of Human Platelet Factor IV with Antibacterial Activity

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1992 Aug 1

PMID 1644916

Citations 30

Authors

R P Darveau

J Blake

C L Seachord

W L Cosand

M D Cunningham

G Maloney

Affiliations

Soon will be listed here.

Abstract

A peptide (C13) corresponding to the last 13 amino acids of the carboxyl terminus of human platelet factor IV was found to be antibacterial. Amino acid substitutions predicted to disrupt either the amphipathic or alpha-helical nature of C13 rendered the peptide inactive. Antibacterial activity was demonstrated in normal human serum on bacteria which had been previously exposed to low levels of cefepime, a beta-lactam antibiotic. Peptide analogues were examined for more potent antibacterial activity in an antibacterial assay that employed normal human serum and low levels of cefepime. A peptide analogue (C18G) with 80-fold more antibacterial activity than C13 was identified. Studies in C8-deficient sera confirmed an essential role of human serum complement for optimal antibacterial activity. Additional studies showed low levels of cefepime, although not essential, enhanced the antibacterial activity of C18G. Animal protection experiments demonstrated that either peptide C18G or an analogue with all D amino acids (C18X) significantly increased the survival of neutropenic mice when coadministered with a low level of cefepime. This work has resulted in the identification of a new group of antibacterial peptides.

Citing Articles

Impacts of Hydrophobic Mismatch on Antimicrobial Peptide Efficacy and Bilayer Permeabilization.

Meier S, Ridgway Z, Picciano A, Caputo G Antibiotics (Basel). 2023; 12(11).

PMID: 37998826 PMC: 10669323. DOI: 10.3390/antibiotics12111624.

Platelet factor 4 improves survival in a murine model of antibiotic-susceptible and methicillin-resistant peritonitis.

Podolnikova N, Lishko V, Roberson R, Koh Z, Derkach D, Richardson D Front Cell Infect Microbiol. 2023; 13:1217103.

PMID: 37868353 PMC: 10585365. DOI: 10.3389/fcimb.2023.1217103.

Insect Antimicrobial Peptides: Advancements, Enhancements and New Challenges.

Dho M, Candian V, Tedeschi R Antibiotics (Basel). 2023; 12(6).

PMID: 37370271 PMC: 10295358. DOI: 10.3390/antibiotics12060952.

How the PhoP/PhoQ System Controls Virulence and Mg Homeostasis: Lessons in Signal Transduction, Pathogenesis, Physiology, and Evolution.

Groisman E, Duprey A, Choi J Microbiol Mol Biol Rev. 2021; 85(3):e0017620.

PMID: 34191587 PMC: 8483708. DOI: 10.1128/MMBR.00176-20.

Effect of Non-natural Hydrophobic Amino Acids on the Efficacy and Properties of the Antimicrobial Peptide C18G.

Hitchner M, Necelis M, Shirley D, Caputo G Probiotics Antimicrob Proteins. 2020; 13(2):527-541.

PMID: 32889698 PMC: 7933317. DOI: 10.1007/s12602-020-09701-3.

References

Tesh V, Duncan Jr R, Morrison D . The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing. J Immunol. 1986; 137(4):1329-35. View

Schiffer M, EDMUNDSON A . Use of helical wheels to represent the structures of proteins and to identify segments with helical potential. Biophys J. 1967; 7(2):121-35. PMC: 1368002. DOI: 10.1016/S0006-3495(67)86579-2. View

Darveau R, Cunningham M, Seachord C, Cosand W, Blake J, Watkins C . Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo. Antimicrob Agents Chemother. 1991; 35(6):1153-9. PMC: 284303. DOI: 10.1128/AAC.35.6.1153. View

Boman H . Antibacterial peptides: key components needed in immunity. Cell. 1991; 65(2):205-7. DOI: 10.1016/0092-8674(91)90154-q. View

Miller M, Garry R, Jaynes J, Montelaro R . A structural correlation between lentivirus transmembrane proteins and natural cytolytic peptides. AIDS Res Hum Retroviruses. 1991; 7(6):511-9. DOI: 10.1089/aid.1991.7.511. View

Stoeckle M, Barker K . Two burgeoning families of platelet factor 4-related proteins: mediators of the inflammatory response. New Biol. 1990; 2(4):313-23. View

Pruul H, Lewis G, McDonald P . Enhanced susceptibility of gram-negative bacteria to phagocytic killing by human polymorphonuclear leucocytes after brief exposure to aztreonam. J Antimicrob Chemother. 1988; 22(5):675-86. DOI: 10.1093/jac/22.5.675. View

Lehrer R, Barton A, Daher K, Harwig S, Ganz T, Selsted M . Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest. 1989; 84(2):553-61. PMC: 548915. DOI: 10.1172/JCI114198. View

Lee S, Mihara H, Aoyagi H, Kato T, IZUMIYA N, Yamasaki N . Relationship between antimicrobial activity and amphiphilic property of basic model peptides. Biochim Biophys Acta. 1986; 862(1):211-9. DOI: 10.1016/0005-2736(86)90485-2. View

10.

Nakajima Y, Qu X, Natori S . Interaction between liposomes and sarcotoxin IA, a potent antibacterial protein of Sarcophaga peregrina (flesh fly). J Biol Chem. 1987; 262(4):1665-9. View

11.

Curtis N, Eisenstadt R, Turner K, White A . Inhibition of penicillin-binding protein 3 of Escherichia coli K-12. Effects upon growth, viability and outer membrane barrier function. J Antimicrob Chemother. 1985; 16(3):287-96. DOI: 10.1093/jac/16.3.287. View

12.

Lee S, Yoshida M, Mihara H, Aoyagi H, Kato T, Yamasaki N . The spectroscopic analysis for binding of amphipathic and antimicrobial model peptides containing pyrenylalanine and tryptophan to lipid bilayer. Biochim Biophys Acta. 1989; 984(2):174-82. DOI: 10.1016/0005-2736(89)90213-7. View

13.

GABRILOVE J, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J . Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med. 1988; 318(22):1414-22. DOI: 10.1056/NEJM198806023182202. View

14.

Sechler J, Malech H, White C, Gallin J . Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood. Proc Natl Acad Sci U S A. 1988; 85(13):4874-8. PMC: 280539. DOI: 10.1073/pnas.85.13.4874. View

15.

Geoffroy C, Gaillard J, ALOUF J, Berche P . Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes. Infect Immun. 1987; 55(7):1641-6. PMC: 260571. DOI: 10.1128/iai.55.7.1641-1646.1987. View

16.

Pruul H, McDonald P . Damage to bacteria by antibiotics in vitro and its relevance to antimicrobial chemotherapy: a historical perspective. J Antimicrob Chemother. 1988; 21(6):695-8. DOI: 10.1093/jac/21.6.695. View

17.

Hammer M, Baltch A, Smith R, CONROY J, Bishop M, Michelsen P . Human granulocyte activity against moxalactam-induced filamentous forms of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1988; 32(10):1565-70. PMC: 175920. DOI: 10.1128/AAC.32.10.1565. View

18.

Luster A, Ravetch J . Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med. 1987; 166(4):1084-97. PMC: 2188708. DOI: 10.1084/jem.166.4.1084. View

19.

Boman H, Wade D, Boman I, Wahlin B, MERRIFIELD R . Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids. FEBS Lett. 1989; 259(1):103-6. DOI: 10.1016/0014-5793(89)81505-4. View

20.

Tanaka T, Okamura S, Okada K, Suga A, Shimono N, Ohhara N . Protective effect of recombinant murine granulocyte-macrophage colony-stimulating factor against Pseudomonas aeruginosa infection in leukocytopenic mice. Infect Immun. 1989; 57(6):1792-9. PMC: 313358. DOI: 10.1128/iai.57.6.1792-1799.1989. View